UAMS Principal Investigator: Kyle Kalkwarf, M.D., assistant professor, College of Medicine Department of Surgery, Division of Trauma and Acute Care Surgery
Summary: This multi-site clinical trial involving hospitalized traumatic brain injury patients will test the effectiveness of a non-invasive device (Infrascanner) for detecting the growth of intracranial hematomas.
Significance: The study of this FDA-approved device, which uses near-infrared light to detect bleeding, may lead to earlier diagnosis and improved treatments for traumatic brain injury patients, especially in areas with limited resources, such as rural America or on military deployments
TRI Services: Medicare coverage analysis, study budget development, regulatory and nurse/clinical coordinator support, administration of Clinical Trial Management System, and post-award financial management
Sponsor: University of Alabama at Birmingham
Funding: U.S. Department of Defense